Episode Summary
Executive Summary: This episode tracks three big shifts: AI is becoming costlier and less obviously profitable for companies, entertainment leaders think AI will augment rather than replace creatives, and GLP-1 drugs may transform healthcare more than AI if the system can deliver them. It also revisits Scott’s support for military action in Iran, which he now says he can no longer defend, and closes with a mental-health lesson: action reduces anxiety.
Main Topics: AI boom meets rising costs and weaker ROI (Priority: 5/5): The hosts argue that the AI narrative is cooling as companies discover that compute and licensing costs can exceed the cost of human workers, making ROI harder to prove despite widespread adoption pressure. AI in entertainment as a creative tool, not a replacement (Priority: 4/5): Netflix co-CEO Ted Sarandos says AI will improve filmmaking and writing workflows, especially in production and pre-vis, but will not replace writers’ rooms or original creativity. GLP-1 drugs vs. AI as the more transformative bet (Priority: 5/5): Scott highlights Eli Lilly’s obesity drugs as potentially more impactful than AI because they work broadly, patients like taking them, and obesity is linked to many chronic diseases. America’s broken healthcare economics (Priority: 5/5): The discussion frames U.S. healthcare as massively expensive yet poor in outcomes, driven less by insurers alone and more by hospital pricing, consolidation, and structural market failure. Reassessing support for military action in Iran (Priority: 4/5): Scott revisits his earlier support for strikes on Iran and says the outcome now looks like a strategic quagmire and a national disaster, with too many promises unfulfilled. ‘Action absorbs anxiety’ as a practical mindset (Priority: 3/5): In the closing happiness segment, Scott argues that taking concrete steps—toward medical care, job search, or other problems—reduces fear better than ruminating.
Key Arguments: AI adoption is being pushed by incentives and hype, but many firms still cannot tie spending to measurable returns. Some companies are already warning that AI costs are becoming harder to justify, suggesting the market may be entering an AI spending correction. In entertainment, AI is best suited to efficiency gains like pre-visualization and workflow support, not to generating original storytelling at the level of a writer’s room. GLP-1 drugs are unusually powerful because they work for most people, improve disease risk, and are highly desired by patients. Even transformative drugs matter less if the U.S. healthcare system cannot affordably and efficiently deliver them. Scott believes his earlier backing of military action against Iran now looks mistaken because the strategic and political payoff has not materialized. Anxiety is reduced by decisive action; moving toward a solution is psychologically stabilizing even before the problem is fully resolved.
Data Points: AI-related layoffs: Nearly 50,000 workers - Layoffs this year said to be tied to AI adoption AI budget overrun: Uber blew through its 2026 AI budget in four months - Example of rising AI costs Market-value IPO pipeline: ~$4 trillion combined valuation - SpaceX, OpenAI, and Anthropic set to go public this year Potential entertainment revenue shift: $60 billion annually - McKinsey estimate of revenue AI could redistribute across film and television within five years U.S. healthcare spending: $5.3 trillion - Americans’ annual health spending last year Per-person healthcare spending: More than $15,000 per person - U.S. healthcare spending level Share of economy: Nearly one-fifth - Healthcare’s share of the U.S. economy Projected healthcare spending by 2033: Climbing to one in every $5 in the American economy - Projected future burden of healthcare costs AI project ROI survey result: About 5% - MIT professor survey finding that only around 5% of token projects can be tied to return Network reach for LinkedIn ads: Over 1 billion professionals and 130 million decision makers - LinkedIn ad platform statistics cited in sponsor read
Pivotal Quotes: "At what point does AI actually stop being worth it?" — Host/Scott discussion: Core question raised as companies report AI costs overtaking expected benefits "AI is not built to do that ever. I mean, the tool itself is built to give you the most predictable outcome possible." — Ted Sarandos: Sarandos explaining why AI cannot replace original creative work in film and television "Action absorbs anxiety." — Scott Galloway: Closing happiness segment about dealing with fear through concrete steps
Implications: The episode suggests AI may face a near-term ROI reckoning, while healthcare and GLP-1s may prove more consequential. For listeners, the message is to separate hype from value, and to act quickly when problems emerge.